Skip to main content
. 2020 Feb 17;5(2):278–285. doi: 10.1002/lio2.362

Table 1.

Factors which univariate analysis revealed were not statistically predictors of recurrence of vestibular schwannoma

Factor Recurrence Nonrecurrence P value
Sex (M/F) 31/70 208/389 .31
Age at diagnosis 50.04 ± 12.60 51.58 ± 11.53 .22
Tumor size (cm) 2.25 ± 1.13 2.08 ± 1.25 .21
Neurofibromatosis .67
Yes 2 (11.7%) 15 (88.3%)
No 77 (15.4%) 424 (84.6%)
Unknown 22 (12.2%) 158 (87.8%)
Surgical approach .12
Translabyrinthine 18 (15.6%) 97 (84.4%)
Retrosigmoid/suboccipital 29 (13.0%) 194 (87.0%)
Middle fossa 7 (12.3%) 50 (87.7%)
Unknown 3 (60.0%) 2 (40.0%)
Medical center .43
Academic hospital 65 (16.4%) 332 (83.6%)
Private hospital 32 (12.9%) 217 (87.1%)
VA hospital 4 (7.7%) 48 (92.3%)
Treatment complicationa .75
Present 12 (13.0%) 80 (87.0%)
Absent 89 (14.7%) 517 (85.3%)

Abbreviations: M/F, male/female ratio; VA, veteran administration.

a

Detailed post‐treatment complications other than noted in Table 2 (ie, tinnitus, imbalance, cognitive problems, cerebrospinal fluid leak, synkinesis, headache, hydrocephalus, meningitis, and stroke) were not statistically different between the recurrence and nonrecurrence groups.